Evidence map›Paper›PMID 42303756›Full record

ArticleNPJ digital medicine2026

Real-world evaluation of large language model for patients medical and administrative queries in nuclear medicine.

Arash Latifoltojar, Akintunde Orunmuyi, Michael Wang, Stefan Adrian Vöö, Irfan Kayani, Richard Oyibo, Kabita Gurung, Jennifer Williams, Memuna Rashid, Andre Lopes and 2 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Arash LatifoltojarInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom. a.latifoltojar@nhs.net.
Akintunde OrunmuyiInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom.
Michael WangInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom.
Stefan Adrian VööInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom.
Irfan KayaniInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom.
Richard OyiboInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom.
Kabita GurungInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom.
Jennifer WilliamsInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom.
Memuna RashidCancer Trials Centre, University College London, London, United Kingdom.
Andre LopesCancer Trials Centre, University College London, London, United Kingdom.
Ashley Macallistar GrovesInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom.
Jamshed BomanjiInstitute of Nuclear Medicine, University College London Hospital and University College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Large language models (LLMs) may support patients by addressing their queries; however, their real-world clinical use remains uncertain. Patients' queries prospectively collected and answered by nuclear medicine physicians, administrative staffs, and ChatGPT v4.1. Responses evaluated and Likert-scored by medical and administrative experts and two independent non-experts using 15 out of 17 dimensions of the proposed QUEST framework. LLM-generated responses classified as "better," "equivalent," or "worse" relative to human-generated responses on question-by-question basis; binomial tests assessed whether LLM performance exceeded 50%. Inter-rater agreement was assessed using Prevalence-Adjusted Bias-Adjusted Kappa (PABAK); statistical significance set at p < 0.05. 339 drug interaction, 42 medical, and 76 administrative queries were analysed. For medical queries, in 8 of 10 dimensions, 76-98% of LLM-generated responses rated equivalent or better than human-generated responses by medical expert (p < 0.001). For administrative queries, non-expert raters judged LLM-generated responses more informative (97%) and preferred (86%). For medical queries, LLM-generated responses rated more informative (67%), human-generated responses judged easier to understand (62%), with 60% disagreement on overall preference. PABAK showed higher agreement for LLM- than human-generated responses across medical (0.14-0.90 vs -0.90-0.52) and administrative (0.92-1.00 vs -0.63- - 0.13) queries. LLM-generated responses were consistently rated favourably, particularly for administrative queries, though further validation is required before clinical use.

Identifiers

PMID42303756
PMCPMC13635222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.